A number of studies have demonstrated that affective disorders in epilepsy represent a common psychiatric comorbidity; however, most of the classic neuropsychiatric literature focuses on depression, which is actually prominent, but little is known about bipolar depression, and very little about mania, in epilepsy. Biochemical, structural, and functional abnormalities in primary bipolar disorder could also occur secondary to seizure disorders. The kindling paradigm, invoked as a model for understanding seizure disorders, has also been applied to the episodic nature of bipolar disorder. In bipolar patients, changes in second-messenger systems, such as G-proteins, phosphatidylinositol, protein kinase C, myristoylated alanine-rich C kinase substrate, or calcium activity have been described, along with changes in c-fos expression. Common mechanisms at the level of ion channels might include the antikindling and the calcium-antagonistic and potassium outward current-modulating properties of antiepileptic drugs. All these lines of research appear to be converging on a richer understanding of neurobiological underpinnings between bipolar disorder and epilepsy. Mania, which is the other side of the coin in affective disorders, may represent a privileged window into the neurobiology of mood regulation and the neurobiology of epilepsy itself. Future research on intracellular mechanisms might become decisive for a better understanding of the similarities between these two disorders. NEUROSCIENTIST 13(4):392—404, 2007. DOI: 10.1177/1073858407301117
Adler CM, DelBello M., Jarvis K., Levine A., Adams J., Strakowski SM2007. Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry61:776—81.
2.
Amann B., Grunze H.2005. Neurochemical underpinnings in bipolar disorder and epilepsy . Epilepsia46:26—30.
3.
Barry JJ2003. The recognition and management of mood disorders as a comorbidity of epilepsy. Epilepsia44:30—40.
4.
American Psychiatric Association.2004. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association.
5.
Bauer M., Pfenning A.2005. Epidemiology of bipolar disorders. Epilepsia46:8—13.
6.
Benes FM, Vincent SL, Todtenkopf M.2001. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry50:395—406.
7.
Berkovic SF, Mulley J., Scheffer IE, Petrou S.2006. Human epilepsies: interaction of genetic and acquired factors. Trends Neurosci29:391—7.
8.
Blumer D., Altshuler LL1998. Affective disorders. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia : Lippincott Raven. p 2083—99.
9.
Blumer D., Montouris G., Hermann BP1995. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J Neuropsychiatry Clin Neurosci7:445—56.
10.
Carran MA, Kohler Cg, O'Connor.2003. Mania following temporal lobectomy. Neurology61:770—4.
11.
Chang K., Adleman N., Dienes K., Barnea-Goraly N., Reiss A., Ketter T.2003. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry53:1059—65.
12.
Chen G., Manji HK2006. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr Opin Psychiatry19:313—23.
13.
Chen G., Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, and others.1999 . The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein Bcl-2 in the CNS. J Neurochem72:879—82.
14.
Chen RW, Chuang DM1999. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression: a prominent role in neuroprotection against excitotoxicity. J Biol Chem274:6039—42.
15.
Chen Y., Lu J., Pan H., Zhang Y., Wu H., Xu K., and others.2003 . Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol54:239—43.
16.
Clark M., Post RM, Weiss SR, Cain CJ, Nakajima T.1991. Regional expression of c-fos mRNA in rat brain during the evolution of amygdala kindled seizures. Brain Res Mol Brain Res11:55—64.
17.
Dibbens LM, Feng HJ, Richards MC, Harkin LA, Hodgson BL, Scott D., and others.2004 . GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet13:1315—9.
18.
Diehl DJ, Gershon S.1992. The role of dopamine in mood disorders. Compr Psychiatry33:115—20.
19.
Dubovsky SL, Thomas M., Hijazi A.1994. Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. Neuropsychobiology27:122—6.
20.
Eastwood SL, Harrison PJ2000. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of the complexin mRNAs. Mol Psychiatry5:425—32.
21.
Einat H., Manji HK2006. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry59:1160—71.
22.
Ettinger AB2006. Psychotropic effects of antiepileptic drugs. Neurology67:1916—25.
23.
Ettinger AB, Reed ML, Goldberg JF, Hirshfield MA2005. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology65:535—40.
24.
Flor-Henry P.1969. Psychosis and temporal-lobe epilepsy: a controlled investigation . Epilepsia10:363—95.
25.
Ghaemi SN, Boiman EE, Goodwin FK1999. Kindling and second messengers: an approach to the neurobiology of recurrence in bipolar disorder. Biol Psychiatry45:137—44.
26.
Gilbert ME2001. Does the kindling model of epilepsy contribute to our understanding of multiple chemical sensitivity?Ann N Y Acad Sci933:68—91.
27.
Goddard GV, McIntyre DC, Leech CK1969. A permanent change in brain function resulting from daily electrical stimulation. ExpertNeurol25:295—330.
28.
Goldberg JF, Harrow M.1994. Kindling in bipolar disorders: a longitudinal follow-up study. Biol Psychiatry35:70—2.
29.
Grunze H., Amann B., Walden J.2002. How might anticonvulsant drugs work in bipolar affective disorder? In: Trimble M, Schmitz B, editors. Seizures, affective disorders and anticonvulsant drugs. Guilford, UK: Clarius.
30.
Guidotti A., Auta J., Davis JM, Gerevini VD, Dwivedi Y., Grayson DR, and others. 2000. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry57:1061—9.
31.
Hauser WA, Kurland LT1993. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia34: 453—68.
32.
Hurwitz TA, Wada JA, Kosaka BA, Strauss EH1985. Cerebral organization of affect suggested by temporal lobe seizures. Neurology35:1335—7.
33.
Jagadheesan K., Garg AK, Nizamie SH2003. Risk factors and outcome of mood disorders in epilepsy: a case-control study. Seizure12:121—5.
34.
Jimerson DC, Nurnberger JI, Post RM, Gershon ES, Kopin IJ1981. Plasma MHPG in rapid cyclers and healthy twins . Arch Gen Psychiatry38:1287—90.
35.
Jobe PC2003. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav4:S14—24.
36.
Jobe PC2004. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches. Clin EEGNeurosci35:53—68.
37.
Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L., Shore AD, Torrey EF, and others. 2000. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry5:142—9.
38.
Kanemoto K., Kawasaki J., Kawai I.1996. Postictal psychosis: a comparison with acute interictal and chronic psychoses. Epilepsia37:551—6.
39.
Kanner AM2004. Is major depression a neurologic disorder with psychiatric symptoms?Epilepsy Behav5:636—44.
40.
Kanner AM, Balabanov A.Depression and epilepsy: how closely related are they? Neurology58(suppl 5):27—39.
41.
Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE, and others.2001 . Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry49:97—109.
42.
Kling MA, Roy A., Doran AR, Calabrese JR, Rubinow DR, Whitfield Hjj, and others.1991 . Cerebrospinal fluid immunoreactive corticotropinreleasing hormone and adrenocorticotropin secretion in Cushings disease and major depression: potential clinical implications. J Clin Endocrinol Metab72:260—71.
43.
Knable MB, Torrey EF, Webster MJ, Bartko JJ2001. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull55:651—9.
44.
Kudo T., Ishida S., Kubota H., Yagi K.2001. Manic episode in epilepsy and bipolar I disorder: a comparative analysis of 13 patients. Epilepsia42:1036—42.
45.
Kupka R., Post R.2002. Kindling as a model for affective disorders. In: Trimble M, Schmitz B, editors. Seizures, affective disorders and anticonvulsant drugs. Guilford, UK: Clarius.
46.
Landolt H.1958. Serial electroencephalographic investigations during psychotic episodes in epileptic patients and during schizophrenic attacks . In: Lorentz de Haas AM, editor. Lectures on epilepsy . Amsterdam: Elsevier. p 91—133.
47.
Manji HK, Potter WZ, Lenox RH1995. Signal transduction pathways: molecular targets for lithium's actions. Arch Gen Psychiatry52:531—43.
48.
Mazza M., Bria P., Janiri L., Mazza S.2006. Neuroendocrinologia dei disturbi dell'umore. Minerva Psichiatrica47:11—24.
49.
Mazza M., Orsucci F., De Risio S., Bria P., Mazza S.2004a. Epilepsy and depression: risk factors for suicide ? Clinica Terapeutica155:425—7.
50.
Mazza M., Satta MA, Bria P., Mazza S.2004b. Neuroendocrinology of mood disorders. Clinica Terapeutica155:537—41.
51.
Miguel-Hidalgo JJ, Baucom C., Dilley G., Overholser JC, Meltzer HY, Stockmeier CA, and others.2000 . Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder . Biol Psychiatry48:861—73.
52.
Morimoto K., Fahnestock M., Racine RJ2004. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol73:1—60.
53.
Mula M., Monaco F.2006. Antiepileptic drug-induced mania in patients with epilepsy: what do we know?Epilepsy Behav9:265—7.
Muzina DJ, Elhaj O., Gajwani P., Gao K., Calabrese JR2005b. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder. Acta Psychiatr Scand Suppl426:21—8.
57.
Nishida T., Kudo T., Inoue Y., Nakamura F., Yoshimura M., Matsuda K., and others.2006 . Postictal mania versus postictal psychosis: differences in clinical features, epileptogenic zone, and brain functional changes during postictal period. Epilepsia47:2104—14.
58.
Nishida T., Kudo T., Nakamura F., Yoshimua M., Matsuda K., Yagi K.2005. Postictal mania associated with frontal lobe epilepsy . Epilepsy Behav6:102—10.
59.
Nonaka S., Katsube N., Chuang DM1998. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Expert Ther286:539—47.
60.
Ongur D., Drevets W., Price JL1998. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA95:13290—5.
61.
Paciello N., Mazza M., Mazza S.2002. Depression and epilepsy: symptom or syndrome? Clinica Terapeutica153:397—402.
62.
Post R., Weiss S., Smith M., Rosen J., Frye M.1995. Stress, conditioning, and the temporal aspects of affective disorders. Biol Psychiatry771:677—96.
63.
Post RM2004. Neurobiology of seizures and behavioral abnormalities . Epilepsia45(suppl 2):5—14.
64.
Post RM, Denicoff KD, Leverich GS, Huggins T., Post SW, Luckenbaugh D.2000a. Neuropsychological deficits of primary affective illness: implications of therapy. Psychiatry Ann30:485—94.
65.
Post RM, Speer AM, Hough CJ, Xing G.2003. Neurobiology of bipolar illness: implications for future study and therapeutics. Ann Clin Psychiatry15:85—94.
66.
Post RM, Speer AM, Weiss SR, Li H.2000b. Seizure models: anticonvulsant effects of ECT and rTMS . Prog Neuropsychopharmacol Biol Psychiatry24:1251—73.
67.
Post RM, Weiss Srb.1997. Kindling and stress sensitization. In: Young LT, Joffe RT, editors. Bipolar disorder: biological models and their clinical application . New York: Marcel Dekker. p 93—126.
68.
Qin P., Xu H., Laursen TM, Vestergaard M., Mortensen PB2005. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ331:23.
69.
Rajkowska G.2000. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry48:766—77.
70.
Rubinow DR, Gold PW, Post RM, Ballenger JC, Cowdry R., Bollinger J., and others.1983 . CSF somatostatin in affective illness. Arch Gen Psychiatry40:409—12.
71.
Rubinow DR, Post RM, Pickar D., Naber D., Ballenger JC, Gold PW, and others.1981 . Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteers. Psychiatry Res5:87—93.
72.
Schmitz B.2005. Depression and mania in patients with epilepsy . Epilepsia46(suppl 4):45—9.
73.
Schurhoff F., Bellivier F., Jouvent R., Mouren-Simeoni MC, Bouvard M., Allilaire JF, and others.2000 . Early and late onset bipolar disorders: two different forms of manic-depressive illness?J Affect Disord58:215—21.
74.
Smoller JW, Finn CT2003. Family, twin, and adoption studies of bipolar disorder . Am J Med Genet123C:48—58.
75.
Speckmann EJ, Straub H., Kohling R.1993. Contribution of calcium ions to the generation of epileptic activity and antiepileptic calcium antagonism. Neuropsychobiology27:122—6.
76.
Sporn J., Sachs G.1997. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol17:185—9.
77.
Starkstein SE, Boston JD, Robinson RG1988. Mechanisms of mania after brain injury: 12 case reports and review of the literature. J Nerv Mental Dis176:87—100.
78.
Strober M., Morrell W., Burroughs J., Lampert C., Danforth H., Freeman R.1988. A family study of bipolar I disorder in adolescence: early onset of symptoms linked to increased familial loading and lithium resistance . J Affect Disord15:255—68.
79.
Weisler RH, Cutler AJ, Ballenger JC, Post RM, Ketter TA2006. The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials. CNS Spectr11:788—99.
80.
Wolf P.1982. Manic episodes in epilepsy. In: Akimoto H, Kazamatsuri H, Seino M, Ward A, editors. Advances in epileptology: XIIIth Epilepsy International Symposium . New York: Raven. p 237—40.
81.
Xing GQ, Russell S., Hough C., O'Grady J., Zhang L., Yang S., and others. 2002. Decreased prefrontal CaMKII α mRNA in bipolar illness. Neuroreport13:501—5.
82.
Yatham LN, Liddle PF, Shiah IS2002. PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium. Am J Psychiatry159:768—74.
83.
Yuan PX, Huang LD, Jiang YM2001. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem276:31674—83.
